Oppenheimer initiated coverage of Ocugen (NASDAQ:OCGN) with an Outperform rating and a $10 price target on Wednesday, ...

CEO Waleed Hassanein and CFO Gerardo Hernandez-Omana provided updates on the company’s strategy, clinical trial planning, and ...

Ocugen, Inc. (NASDAQ:OCGN) is one of the High-Flying Penny Stocks to Buy. On March 11, Ocugen, Inc. (NASDAQ:OCGN) was ...

Detailed price information for Corvus Pharma Com (CRVS-Q) from The Globe and Mail including charting and trades.

Ocugen Inc OCGN shares are surging on Wednesday afternoon after Oppenheimer analyst Leland Gershell initiated coverage with an Outperform rating and a $10 price target. Here’s what investors need to ...

From Rear Window to Shutter Island, these masterfully crafted thrillers prove why suspense storytelling can trap audiences in ...

Mark Guerin, CPA, CMA, CFM, Annovis' CFO, has an extensive background in biopharma financial operations, including financial reporting, forecasting, internal controls, IPOs, follow-on offerings, and ...

Cillian Murphy is officially proves he's the Immortal Man in blockbuster Netflix debut for the Peaky Blinders movie.

Lo detailed that the Dynavax partnership, announced in November 2025, included a $25 million upfront payment and $5 million equity investment. The agreement holds "a total potential value of up to ...

But 2026 is already gearing up to be just as exciting. Whether you’re a “Toy Story” fan, or Christopher Nolan’s latest epic ...

Olema Pharmaceuticals (OLMA) stock surged 8.5% after beating Q4 earnings estimates. Analysts maintain bullish stance despite ...

Oppenheimer analyst Kostas Biliouris maintained a Buy rating on PepGen Inc. today and set a price target of $15.00. Claim 70% Off TipRanks Premium. Unlock hedge fund-level data an ...